Hexarelin
| Paramètre | Spécifications |
|---|---|
| Nom du produit | Hexarelin |
| Numéro CAS | 140703-51-1 |
| Formule moléculaire | C47H58N12O6 |
| Poids moléculaire | 887.0 g/mol |
| Apparence | White to off-white lyophilized powder |
| Essai (HPLC) | ≥98,01 TP3T |
| Solubilité | Soluble in water and aqueous buffers |
| Colis | 1 g / 5 g / 10 g / 100 g |
Besoin d'aide ? Contacter notre équipe

Synonymes : Hexarelin, Examorelin, Hexarelin acetate, EP 23905, L-Histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, 140703-51-1
Hexarelin is a synthetic hexapeptide supplied as a white to off-white lyophilized powder. It is manufactured by solid-phase peptide synthesis and purified by preparative HPLC to a purity of ≥98%. Each batch is tested for identity, purity, and peptide content before release.
For formulators, the key considerations are solubility in aqueous media and stability of the lyophilized powder under recommended storage conditions. The peptide dissolves readily in water and aqueous buffers, which supports its use in injectable and research formulations. It is not intended for topical or oral delivery systems.
Typical end uses include research and development of peptide-based injectables, reference standards for analytical testing, and small-scale compounding. The material is supplied as a free-flowing powder that can be accurately weighed and reconstituted under aseptic conditions.
Hexarelin is primarily used in the research and development of injectable peptide formulations, where it serves as an active pharmaceutical ingredient (API) or as a reference standard for analytical method development. It is also used in small-scale compounding for clinical trials and in the production of diagnostic kits.
In formulation, the peptide is typically dissolved in sterile water or saline and filtered through a 0.22 µm membrane before filling. It is compatible with common excipients used in lyophilized or liquid injectables. The powder should be handled under controlled humidity to avoid moisture uptake.
Hexarelin is produced via solid-phase peptide synthesis using Fmoc chemistry. The crude peptide is purified by reverse-phase HPLC and converted to the acetate salt. The final product is lyophilized and milled to a uniform powder. Production is carried out in a GMP-compliant facility, and each batch is accompanied by a certificate of analysis.
send us your specification for a quotation.
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China